Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

pfe


Fundamental

Company: Pfizer Inc
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: USA
Exchange: NYSE
Index: S&P 500
P/E: 35.43
EPS (ttm): 0.74
Insider Own: 0.03%
Shs Outstand: 5.67B
Perf Week: 3.05%
Market Cap: 152.80B
Forward P/E: 9.11
EPS next Y: 2.89
Insider Trans: -0.24%
Shs Float: 5.67B
Perf Month: 5.69%
Income: 4.27B
PEG: 4.69
EPS next Q: 0.47
Inst Own: 67.55%
Short Float: 1.60%
Perf Quarter: -10.06%
Sales: 60.11B
P/S: 2.54
EPS this Y: 58.80%
Inst Trans: 0.25%
Short Ratio: 2.19
Perf Half Y: -7.05%
Book/sh: 16.29
P/B: 1.62
EPS next Y Percentage: -0.92%
ROA: 1.97%
Short Interest: 90.38M
Perf Year: -4.60%
Cash/sh: 1.72
P/C: 15.35
EPS next 5Y: 7.55%
ROE: 4.52%
52W Range From: 24.48
52W Range To: 31.54
Perf YTD: -8.44%
Dividend Est.: 1.67 (6.32%)
P/FCF: 18.57
EPS past 5Y: -27.43%
ROI: 2.84%
52W High: -16.42%
Beta: 0.62
Dividend TTM: 1.68 (6.37%)
Quick Ratio: 0.73
Sales past 5Y: 10.96%
Gross Margin: 58.50%
52W Low: 7.68%
ATR (14): 0.61
Dividend Ex-Date: Jan 24, 2025
Current Ratio: 1.00
EPS Y/Y TTM: -59.54%
Oper. Margin: 16.32%
RSI (14): 53.04
Volatility W: 2.41%
Volatility M: 2.09%
Employees: 88000
Debt/Eq: 0.73
Sales Y/Y TTM: -12.29%
Profit Margin: 7.11%
Recom: 2.23
Target Price: 31.50
Option/Short: Yes / Yes
LT Debt/Eq: 0.63
EPS Q/Q: 284.91%
Payout: 439.41%
Rel Volume: 2.82
Prev Close: 25.77
Sales Surprise: 18.63%
EPS Surprise: 72.53%
Sales Q/Q: 33.78%
Earnings: Oct 29 BMO
Avg Volume: 41.19M
Price: 26.36
SMA20: 2.33%
SMA50: -1.96%
SMA200: -5.76%
Trades:
Volume: 116,140,902
Change: 2.29%

Technical:


Latest News:

REG - Goldman Sachs Intl Pfizer Inc Haleon PLC - Proposed Offering of Ordinary Shares in ... neutral
PFE

Summary: Pfizer Inc. intends to sell approximately 540 million ordinary shares in Haleon plc, representing approximately 5.9% of Haleon's issued share capital, through an accelerated bookbuilding process. The completion of the offering will be followed by a share buyback agreement where Haleon will purchase shares from Pfizer.

Full article
2024-09-30T16:08:30Z
Pfizer intends to sell about 540M ordinary shares in Haleon - TipRanks.com somewhat bearish
PFE HLN

Summary: Pfizer (PFE) announces intention to sell approximately 5.9% of Haleon plc's issued share capital through an accelerated bookbuilding process to institutional investors.

Full article
2024-09-30T16:06:00Z
Analysis Group Provides Support for Ranbaxy and Pfizer in Defeat of Lipitor Reverse ... somewhat bullish
PFE OTRK

Summary: Analysis Group provided expert testimony in a long-running antitrust case involving Pfizer and Ranbaxy's alleged delayed market entry for generic Lipitor, ultimately resulting in the court denying plaintiffs' motions for certification and granting defendants' motion for summary judgment.

Full article
2024-09-23T14:58:31Z
Pfizer introduces a new breakthrough for acute migraine relief in the UAE, aiming to ... very bullish
PFE

Summary: Pfizer launching a new breakthrough for acute migraine treatment with a nasal spray that provides pain relief in as early as 15 minutes.

Full article
2024-09-19T22:18:13Z
Directing Patients to M3P, Pfizer Notice Hints at 'Pulling Back' Assis - AIS Health somewhat bearish
PFE

Summary: Medicare Advantage insurers and distribution partners are expecting a busy Annual Election Period due to multiple Part D benefit changes, as well as concerns about market disruption and enrollee confusion stemming from a new drug manufacturer letter regarding Patient Assistance Programs (PAPs) and the Medicare Payment Prescription Plan (M3P). Pfizer Inc. has informed Part D beneficiaries about the need to enroll in M3P before being reconsidered for PAP through its Pfizer Oncology Together program.

Full article
2024-09-19T18:42:55Z
ABRYSVO™: Pfizer Canada's Newly Publicly Funded Vaccine a Step Towards National ... somewhat bullish
PFE

Summary: Pfizer Canada announces the selection of ABRYSVO™ as the publicly-funded vaccine for the prevention of Respiratory Syncytial Virus (RSV) in older adults in Canada for 2024-2025, provinces and territories introducing ABRYSVO™ to their publicly funded immunization programs, NACI's strong recommendation on RSV immunization programs for older adults.

Full article
2024-09-19T14:52:01Z
Pfizer Rotational Program Spotlight - All Together neutral
PFE

Summary: Pfizer offers rotational programs for college graduates lasting 24 months with various rotations aimed at skill development and finding the best fit for individuals and the organization. A Digital Rotational colleague shares her experience working on impactful projects.

Full article
2024-09-18T14:05:49Z
Pfizer/Valneva share promising results for Lyme disease vaccine candidate - PMLiVE very bullish
PFE VALN

Summary: Pfizer and Valneva have shared promising immune response and safety results from a mid-stage study of their Lyme disease vaccine candidate, demonstrating significant anamnestic antibody response across all six serotypes covered by the vaccine.

Full article
2024-09-06T11:31:31Z
Pfizer names Elif Aral president of MERA - BioCentury neutral
PFE PXMD JNJ

Summary: Pfizer appoints Elif Aral as regional president for Middle East, Russia and Africa while CEO Amy Emerson steps down at Lykos with new CMO David Hough.

Full article
2024-09-06T06:15:12Z
Pfizer surges 3% as investors cheer 350% dividend announcement; details very bullish
PFE

Summary: Shares of pharmaceutical company Pfizer jumped nearly 3 per cent to Rs 6,068.10 during intra-day trade on Wednesday following the announcement of a 350 per cent dividend of Rs 35 per share for FY24. Pfizer trading ex-dividend today.

Full article
2024-08-21T11:27:50Z
Pfizer denies offering Seoul double Paxlovid's supply price < Pharma < Article - KBR neutral
PFE

Summary: Pfizer Korea denied reports of requesting to double the supply price of its Covid-19 drug Paxlovid, ensuring ongoing discussions and cooperation with the government.

Full article
2024-08-21T10:08:52Z
Artemis Hospitals unveils specialised centre for adult vaccination in collaboration with Pfizer India somewhat bullish
PFE

Summary: Artemis Hospitals, in partnership with Pfizer India, launched a Centre for Adult Vaccination to address high mortality due to vaccine preventable disease in India. The centre will provide comprehensive knowledge and assistance to patients regarding adult vaccinations.

Full article
2024-08-08T09:45:27Z